KAILUA-KONA, Hawaii, March 06, 2018 -- Nutrex Hawaii, Inc. is pleased to announce that its BioAstin® Hawaiian Astaxanthin® and MD Formulas™ have received The International GMO Evaluation and Notification Program™ (IGEN) verification. BioAstin Hawaiian Astaxanthin is a powerful antioxidant supplement derived from natural microalgae grown on the Kona Coast of the Big Island of Hawaii.
“We chose to verify our astaxanthin products with IGEN, because it assures our commitment to consumer trust and transparency,” said Mawae Morton, CEO, Nutrex Hawaii, Inc. “Ensuring that our astaxanthin and other ingredients in our products are natural, non-synthetic, and GMO-free reinforces our dedication to providing high quality microalgae products from natural ingredients and sources to our valued consumers. Non-GMO verified and non-synthetic products are what our consumers want, and we are dedicated to delivering on this expectation. Our consumers seek natural products because synthetic ingredients are often derived from petrochemicals.”
IGEN is a third-party certification program developed to test for the presence of EU classified genetically modified organisms (GMOs), including both proteins and genes. The IGEN programs rigorous standards require that products must contain undetectable amounts of GMO proteins equivalent to <0.1% GMO.
“Our BioAstin Hawaiian Astaxanthin continues to be the only astaxanthin grown and processed in the state of Hawaii. We take great pride in being able to utilize the natural environment around us to effectively grow microalgae and offer a high-quality dietary supplement as a result. In addition to third-party quality testing such as IGEN, BioAstin undergoes rigorous in-house testing for contaminants such as herbicides, pesticides, heavy metals, and identity. Our quality standards ensure that our astaxanthin is some of the cleanest and purest astaxanthin available on the market. We believe our consumers appreciate our commitment and dedication to producing a superior quality and a locally grown product. We thank our customers for continuing to make BioAstin Hawaiian Astaxanthin their number one choice for astaxanthin,” added Morton.
BioAstin Hawaiian Astaxanthin is the top selling brand of astaxanthin in the state of Hawaii and across the entire US mainland.† BioAstin helps support recovery from intense exercise as well as support skin, cardiovascular, and eye health.* BioAstin is also certified gluten-free by the Gluten Intolerance Group (GIG) and verified as natural astaxanthin by the Natural Algae Astaxanthin Association (NAXA).
†Per SPINS data in the natural channel
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
About Nutrex Hawaii
Nutrex Hawaii was founded in Kailua-Kona, Hawaii in 1990. Our founder, Dr. Gerald Cysewski, chose the pristine Kona Coast of Hawaii due to the pure, unpolluted, clean growing location and access to deep ocean water from a depth of 2000 feet. Our 90-acre facility is located in a BioSecure zone, free of all pesticides and herbicides. Direct from the manufacturer, our Hawaiian Spirulina® and BioAstin® Hawaiian Astaxanthin® are guaranteed to be grown and harvested in Hawaii. Learn more at http://www.nutrex-hawaii.com and please follow us on Facebook (Facebook.com/NutrexHawaii), Twitter (@supernutrient) and Instagram (@ITakeBioAstin).
Media Contact: Tanya Khani, Dunn Pellier Media, 310-362-6131, [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



